The DOI matches its Crossref record, with a small difference in title or year; 94 of the 96 references it cites were found in a registry or an index; none of the 71 sources its claims cite is checked for support yet.
Obesity and Cardiovascular Disease
Open accessAbstract
Obesity has reached global epidemic proportions in both adults and children and is associated with numerous comorbidities, including hypertension (HTN), type II diabetes mellitus, dyslipidemia, obstructive sleep apnea and sleep-disordered breathing, certain cancers, and major cardiovascular (CV) diseases. Because of its maladaptive effects on various CV risk factors and its adverse effects on CV structure and function, obesity has a major impact on CV diseases, such as heart failure (HF), coronary heart disease (CHD), sudden cardiac death, and atrial fibrillation, and is associated with reduced overall survival. Despite this adverse association, numerous studies have documented an obesity paradox in which overweight and obese people with established CV disease, including HTN, HF, CHD, and peripheral arterial disease, have a better prognosis compared with nonoverweight/nonobese patients. This review summarizes the adverse effects of obesity on CV disease risk factors and its role in the pathogenesis of various CV diseases, reviews the obesity paradox and potential explanations for these puzzling data, and concludes with a discussion regarding the current state of weight reduction in the prevention and treatment of CV diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 71 cited sources checked · 0 supported · 0 flagged
In the paper
“In a study of 530 patients, we noted marked improvements in CHD risk factors among overweight and obese CHD patients who lost weight, including CRP, lipids, and glucose, and this group had a trend of lower mortality (48).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [48] Lavie, 2009, The obesity paradox, weight loss, and coronary disease, Am J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In a small subgroup of 45 obese patients with 5% or more weight loss (average 10%) after cardiac rehabilitation, we noted more significant improvements in exercise capacity and plasma lipids than in 81 obese patients who did not lose weight (76).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [76] Lavie, 1997, Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In a study of 530 patients, we noted marked improvements in CHD risk factors among overweight and obese CHD patients who lost weight, including CRP, lipids, and glucose, and this group had a trend of lower mortality (48).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [48] Lavie, 2009, The obesity paradox, weight loss, and coronary disease, Am J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In a study of 5,881 Framingham Heart Study participants, Kenchaiah et al. (30) showed that during a 14-year follow-up, for every 1 kg/m 2 increment in BMI, the risk of HF increased 5% in men and 7% in women.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [30] Kenchaiah, 2002, Obesity and the risk of heart failure, N Engl J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“These abnormalities not only increase the risk of HF, but LA enlargement may increase the risk of AF and its morbid complications discussed later (20).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
- Not checked yetcites [20] Wang, 2004, Obesity and the risk of new-onset atrial fibrillation, JAMA source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“In contrast, however, other studies assessing mortality based on body fat and lean mass rather than BMI or weight alone have suggested that subjects losing body fat rather than lean mass have a lower mortality (67,69).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“During 2-year follow up, all-cause mortality was 30% lower in overweight and obese patients, despite less effective blood pressure control in these patients compared with the normal weight group.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [25] Uretsky, 2007, Obesity paradox in patients with hypertension and coronary artery disease, Am J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“In addition to LV structural abnormalities, obesity also leads to left atrial (LA) enlargement, both from increased circulating blood volume as well as abnormal LV diastolic filling (14,19).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Even independent of arterial pressure and age, obesity increases the risk of left ventricular hypertrophy (LVH), as well as other structural abnormalities, including concentric remodeling (CR) and concentric LVH (18).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
- Not checked yetcites [18] Lavie, 2007, Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Despite this adverse association, numerous studies have documented an obesity paradox in which overweight and obese people with established CV disease, including HTN, HF, CHD, and peripheral arterial disease, have a better prognosis compared with nonoverweight/ nonobese patients.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 26
- Probably not a substantial claim. 2
- The quote only partly states this claim. 2
In the paper
“Recently, we noted marked reductions after cardiac rehabilitation in CRP levels in obese CHD patients, whereas lean patients had only slight and nonsignificant declines in CRP (77).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [77] Lavie, 2008, Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients, J Cardiometab Syndr source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Considering that some long-term studies have shown that weight loss in overweight and obesity is associated with increased mortality coupled with many CV studies showing a better prognosis with a higher BMI, it has been suggested that purposeful weight loss may not be beneficial and may even be detrimental in patients with CV diseases (31,66 -68).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [31] Horwich, 2001, The relationship between obesity and mortality in patients with heart failure, J Am Coll Cardiol source
- Not checked yetcites [66] Fonarow, 2002, Obesity, weight reduction and survival in heart failure: reply, J Am Coll Cardiol source
- Not checked yetcites [67] Allison, 1999, Weight loss increases and fat loss decreases all-cause mortality rates: results from two independent cohort studies, Int J Obes Relat Metab Disord source
- Not checked yetcites [68] Sierra-Johnson, 2008, Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index, Eur Cardiovasc Prev Rehabil source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The adipocyte acts as an endocrine organ, and plays a substantial role in the pathogenesis and complications of obesity (1,10).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Pathophysiology
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Recent evidence indicates that obesity is associated with more morbidity than smoking, alcoholism, and poverty, and if current trends continue, obesity may soon overtake cigarette abuse as the leading cause of preventable death in the U.S. (6 -8).”
What the sources say
- Not checked yetcites [6] Lavie, 2003, Obesity and cardiovascular disease: the Hippocrates paradox?, J Am Coll Cardiol source
- Not checked yetcites [7] Manson, 2003, Obesity in the United States: a fresh look at its high toll, JAMA source
- Not checked yetcites [8] Sturm, 2001, Does obesity contribute as much to morbidity as poverty or smoking?, Public Health source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In fact, OSA may contribute to the pathogenesis of HTN and increased inflammation and CRP (61).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > -Hippocrates (54)
What the sources say
- Not checked yetcites [61] Shamsuzzaman, 2002, Elevated C-reactive protein in patients with obstructive sleep apnea, Circulation source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“with the prevalence among adults increasing by nearly 50% during the 1980s and 1990s (5); now, nearly 70% of adults are classified as overweight or obese compared with fewer than 25% 40 years ago (5)(6)(7).”
What the sources say
- Not checked yetcites [5] Flegal, 2002, Prevalence and trends in obesity among US adults, 1999–2000, JAMA source
- Not checked yetcites [6] Lavie, 2003, Obesity and cardiovascular disease: the Hippocrates paradox?, J Am Coll Cardiol source
- Not checked yetcites [7] Manson, 2003, Obesity in the United States: a fresh look at its high toll, JAMA source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Obesity is a classic cause of alveolar hypoventilation and the obstructive sleep apnea (OSA) syndrome (60).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > -Hippocrates (54)
What the sources say
- Not checked yetcites [60] Trollo, 1996, Obstructive sleep apnea, N Engl J Med source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“We have also documented the inverse relationship between BMI and all-cause mortality in over 30,000 patients with preserved LV systolic function referred for echocardiography (18).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [18] Lavie, 2007, Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because of its maladaptive effects on various CV risk factors and its adverse effects on CV structure and function, obesity has a major impact on CV diseases, such as heart failure (HF), coronary heart disease (CHD), sudden cardiac death, and atrial fibrillation, and is associated with reduced overall survival.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“However, in patients with a BMI Ն35 kg/m 2 , there was an excess risk for CV mortality without any increase in total mortality.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [47] Romero-Corral, 2006, Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies, Lancet source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Obesity has reached global epidemic proportions in both adults and children and is associated with numerous comorbidities, including hypertension (HTN), type II diabetes mellitus, dyslipidemia, obstructive sleep apnea and sleep-disordered breathing, certain cancers, and major cardiovascular (CV) diseases.”
What the sources say
- Not checked yetcites [6] Lavie, 2003, Obesity and cardiovascular disease: the Hippocrates paradox?, J Am Coll Cardiol source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Typically, obese patients have a higher cardiac output but a lower level of total peripheral resistance at any given level of arterial pressure (14,15).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In the subgroup of 5 population-based studies enrolling 78,602 patients, obese patients had a nearly 50% increased risk of developing AF that escalated with increasing BMI.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [52] Wanahita, 2008, Atrial fibrillation and obesity—results of a meta-analysis, Am Heart J source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Likewise, in an analysis of BMI and in-hospital mortality for 108,927 decompensated HF patients, higher BMI was associated with lower mortality (35).”
- Also stated in: § Clinical Consequences of Obesity · plain
“In fact, for every 5-unit increase in BMI, the risk of mortality was 10% lower (p Ͻ 0.001).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [35] Fonarow, 2007, An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the acute decompensated heart failure national registry, Am Heart J source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Clinical Consequences of Obesity · plain
In the paper
“A recent study of nearly 360,000 participants from 9 European countries showed that both general obesity and abdominal adiposity are associated with risk of death and support the importance of WC or WHR in addition to BMI for assessing mortality risk (4).”
What the sources say
- Not checked yetcites [4] Pischon, 2008, General and abdominal adiposity and risk of death in Europe, N Engl J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Certainly, starvation, very-low-calorie diets, liquid protein diets, and obesity surgeries have been associated with prolongation of the QTc interval and increased risk of malignant dysrhythmias (1), and various pharmacologic agents have either limited efficacy or considerable toxicity (70 -72).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [1] Poirier, 2006, Circulation source
- Not checked yetcites [70] Connolly, 1997, Valvular heart disease associated with fenfluramine-phentermine, N Engl J Med source
- Not checked yetcites [71] Albenhaim, 1996, Appetite-suppressant drugs and the risk of primary pulmonary hypertension, N Engl J Med source
- Not checked yetcites [72] Zannad, 2002, Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction, Am Heart J source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Obesity increases total blood volume and cardiac output, and cardiac workload is greater in obesity.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
- Not checked yetcites [14] Alpert, 2001, Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome, Am J Med Sci source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This study also showed a powerful obesity paradox, with progressive reductions in mortality in normal BMI, overweight, and obese groups compared with underweight patients.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [50] Galal, 2009, The obesity paradox in patients with peripheral arterial disease: the influence of chronic obstructive pulmonary disease, Chest source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
None of the sources cited for this claim have been checked yet.
In the paper
“In fact, for each 1-U increase in BMI, there was an increase of 4% in the risk of ischemic stroke and 6% for hemorrhagic stroke (1,53).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Obesity and stroke.
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In a multivariate model, leptin was an independent predictor of CV events, whereas CRP was not.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Pathophysiology
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Recently, increased concentrations of both CRP and leptin were associated with an increased risk of major CV events, but leptin seems to be a more robust predictor (13).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Pathophysiology
What the sources say
- Not checked yetcites [13] Romero-Corral, 2008, Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population, Nat Clin Pract Cardiovasc Med source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“a recent small study suggests that bariatric surgery is safe and effective in patients with severe systolic HF (87).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [87] Ramani, 2008, Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure, Clin Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In HF, despite the obesity paradox, trials have suggested that weight loss can induce improvements in LV mass as well as in systolic and diastolic ventricular function (14).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [14] Alpert, 2001, Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome, Am J Med Sci source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Although 30-day mortality after gastric bypass has recently been reported to be higher than expected, closely linked to surgeon inexperience (80)”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [80] Flum, 2004, Impact of gastric bypass operation on survival: a population-based analysis, J Am Coll Surg source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Weight loss also was associated with marked improvements in LV chamber size, LV end-systolic wall stress, and systolic and diastolic LV function.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [23] Alpert, 1997, Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These studies support purposeful weight reduction in overweight and obese CHD patients, despite the obesity paradox.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“more studies are now showing that these surgical procedures are associated with short-and long-term improvements in major morbidity and all-cause mortality, particularly related with cancers, DM, and CV diseases”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [81] Adams, 2007, Long-term mortality after gastric bypass surgery, N Engl J Med source
- Not checked yetcites [82] Sjöström, 2007, Effects of bariatric surgery on mortality in Swedish obese subjects, N Engl J Med source
- Not checked yetcites [83] Christou, 2004, Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients, Ann Surg source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further weight reduction cannot be considered protective against CVD.366 -369”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [369]
In the citing paper
“If, at the population level, obesity is associated with an increased risk of CVD incidence and mortality, among those with established coronary artery disease, the evidence is contradictory.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [369]
In the citing paper
“Systematic reviews of patients with coronary artery disease or undergoing PCI have suggested an 'obesity paradox' whereby obesity appears protective against an adverse prognosis.366 -369”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [369]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Clearly lifestyle interventions, including exercise training and at least mild weight reduction with caloric restriction, showed a nearly 60% reduction in the risk of developing DM, which was considerably better than that noted in patients treated with metformin (73, 74 ).”
BackgroundPrevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
General and abdominal adiposity and risk of death in Europe
Pischon, T., Boeing, H., Hoffmann, K., Bergmann, M., Schulze, M. B., Overvad, K., van der Schouw, Y. T., Spencer, E., Moons, K. G. M., Tjønneland, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801891 · Cited by 2,155
Romero-Corral, A., Montori, V. M., Somers, V. K., Korinek, J., Thomas, R. J., Allison, T. G., Mookadam, F., & Lopez-Jimenez, F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69251-9 · Cited by 1,652
Flagged first, then by citations
2 of the 96 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,001
Dahlberg, S. E., Schiller, J. H., Bonomi, P., Sandler, A. B., Brahmer, J. R., Ramalingam, S. S., & Johnson, D. H. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31829cf942 · Cited by 106
BMI–Mortality Paradox and Fitness in African American and Caucasian Men With Type 2 Diabetes
Kokkinos, P. F., MYERS, J. N., Faselis, C. J., Doumas, M. N., Kheirbek, R., & Nylén, E. (2012) · Diabetes Care · doi:10.2337/dc11-2407 · Cited by 108
Body mass index and all‐cause mortality in older adults: A scoping review of observational studies
Javed, A. A., Aljied, R., Allison, D. J., Anderson, L. N., Ma, J., & Raina, P. S. (2020) · Obesity Reviews · doi:10.1111/obr.13035 · Cited by 106
The Roles of CCR9/CCL25 in Inflammation and Inflammation-Associated Diseases
Wu, X., Sun, M., Yang, Z. P., Lu, C., Wang, Q., Wang, H., Deng, C., Liu, Y., & Yang, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.686548 · Cited by 105
The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis
Muse, E. D., Feldman, D. I., Blaha, M. J., Dardari, Z., Blumenthal, R. S., Budoff, M. J., Nasir, K., Criqui, M. H., Cushman, M., McClelland, R. L., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.044 · Cited by 104
Stress-related eating, mindfulness, and obesity.
Cotter, E. W., & Kelly, N. R. (2018) · Health Psychology · doi:10.1037/hea0000614 · Cited by 110
López-Jiménez, F. A., & Cortés-Bergoderi, M. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2010.10.010 · Cited by 103
Kwon, Y., Kim, H. J., Park, S. S., Park, Y. G., & Cho, K.-H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168247 · Cited by 103
Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe
Magnussen, C., Niiranen, T., Ojeda, F., Gianfagna, F., Blankenberg, S., Vartiainen, E. A., Sans, S., Pasterkamp, G., Hughes, M., Costanzo, S., et al. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2018.08.008 · Cited by 103
The relationship between obesity and coronary artery disease
Jahangir, E., Schutter, A. D., & Lavie, C. J. (2014) · Translational research · doi:10.1016/j.trsl.2014.03.010 · Cited by 105
Self-citationThe Role of Adiponectin in Endothelial Dysfunction and Hypertension
Rojas, E., Rodríguez-Molina, D., Bolli, P., Israili, Z. H., Faría, J., Fidilio, E., Bermúdez, V., & Velasco, M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0463-7 · Cited by 104
Exercise Like a Hunter-Gatherer: A Prescription for Organic Physical Fitness
O’Keefe, J. H., Vogel, R. A., Lavie, C. J., & Cordain, L. (2011) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2011.03.009 · Cited by 114
Self-citationO'Hara, B. J., Phongsavan, P., Venugopal, K., Eakin, E., Eggins, D., Caterson, H., King, L. A., Allman-Farinelli, M. A., Haas, M. R., & Bauman, A. E. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2012.07.022 · Cited by 101
Abdominal obesity and risk of CVD: a dose–response meta-analysis of thirty-one prospective studies
Xue, R., Li, Q., Geng, Y., Wang, H., Wang, F., & Zhang, S. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521000064 · Cited by 101
Shu, L., Hoo, R. L. C., Wu, X., Pan, Y., Lee, I. P. C., Cheong, L. Y., Bornstein, S. R., Rong, X., Guo, J., & Xu, A. (2017) · Nature Communications · doi:10.1038/ncomms14147 · Cited by 101
Excess Visceral Adipose Tissue/Ectopic Fat
Després, J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.063 · Cited by 103
Tuomilehto, H., Gylling, H., Peltonen, M., Martikainen, T., Sahlman, J., Kokkarinen, J. I., Randell, J. T., Tukiainen, H. O., Vanninen, E. J., Partinen, M., et al. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29485 · Cited by 100
Obesity and the Obesity Paradox in Heart Failure
Gupta, P. P., Fonarow, G. C., & Horwich, T. B. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.08.004 · Cited by 101
Evidence in Guidelines for Treatment of Coronary Artery Disease
Jia, S., Liu, Y., & Yuan, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2517-9_2 · Cited by 102
Strong, A. L., Burow, M. E., Gimble, J. M., & Bunnell, B. A. (2014) · Stem Cells · doi:10.1002/stem.1857 · Cited by 102
Lavie, C. J., Milani, R. V., Ventura, H. O., & Romero‐Corral, A. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0333 · Cited by 99
Self-citationAdamopoulos, C., Meyer, P., Desai, R. V., Karatzidou, K., Ovalle, F., White, M., Aban, I., Love, T. E., DEEDWANIA, P. C., Anker, S. D., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq159 · Cited by 99
Campos, J., Schmeda‐Hirschmann, G., Elba Leiva, M., Guzmán, L., Orrego, R., Fernández, P., González, M., Radojkovic, C., Zuñiga, F. A., Lamperti, L., et al. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.11.018 · Cited by 97
Hypertension and obstructive sleep apnoea syndrome: current perspectives
Baguet, J.-P., Barone‐Rochette, G., & Pépin, J. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2008.147 · Cited by 97
Type D Personality and All-Cause Mortality in Cardiac Patients-Data From a German Cohort Study
Grande, G., Romppel, M., Vesper, J.-M., Schubmann, R., Glaesmer, H., & Herrmann‐Lingen, C. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318227a9bc · Cited by 96
Ladeiras‐Lopes, R., Sampaio, F., Bettencourt, N., Fontes‐Carvalho, R., Ferreira, N. D., Leite-Moreira, A. F., & Gama, V. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2016.09.010 · Cited by 100
Shostrom, D. C. V., Sun, Y., Oleson, J. J., Snetselaar, L. G., & Bao, W. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00144 · Cited by 96
New insights into the true nature of the obesity paradox and the lower cardiovascular risk
Chrysant, S. G., & Chrysant, G. S. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2012.11.008 · Cited by 96
The Obesity Paradox and Cardiovascular Disease
Morse, S. A., Gulati, R., & Reisin, E. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0099-1 · Cited by 97
Gong, M., Wen, S., Nguyen, T., Wang, C., Jin, J., & Zhou, L. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s232377 · Cited by 95
Heo, M., Kim, R. S., Wylie‐Rosett, J., Allison, D. B., Heymsfield, S., & Faith, M. S. (2011) · Obesity Facts · doi:10.1159/000335279 · Cited by 94
Mody, N., Graham, T. E., Tsuji, Y., Yang, Q., & Kahn, B. B. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00521.2007 · Cited by 94
Salmerón, C. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.161588 · Cited by 93
Lyerly, G. W., Sui, X., Lavie, C. J., Church, T. S., Hand, G. A., & Blair, S. N. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.9.780 · Cited by 94
Self-citationSelf-reported Sleep Duration and Prediction of Proteinuria: A Retrospective Cohort Study
Yamamoto, R., Nagasawa, Y., Iwatani, H., Shinzawa, M., Obi, Y., Teranishi, J., Ishigami, T., Yamauchi‐Takihara, K., Nishida, M., Rakugi, H., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.08.032 · Cited by 93
Artham, S. M., Lavie, C. J., Milani, R. V., & Ventura, H. O. (2009) · PubMed Central · Cited by 94
Self-citationObesity, Diabetes and Atrial Fibrillation; Epidemiology, Mechanisms and Interventions
Asghar, O., Alam, U., Hayat, S. A., Aghamohammadzadeh, R., Heagerty, A. M., & Malik, R. A. (2012) · Current Cardiology Reviews · doi:10.2174/157340312803760749 · Cited by 94
Body Fat Is Associated With Reduced Aortic Stiffness Until Middle Age
Corden, B., Keenan, N., de Marvao, A., Dawes, T. J. W., Cesare, A. D., Diamond, T., Durighel, G., Hughes, A. D., Cook, S. A., & O’Regan, D. P. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01177 · Cited by 92
Singh, P., Subramanian, A., Adderley, N. J., Gokhale, K. M., Singhal, R., Bellary, S., Nirantharakumar, K., & Tahrani, A. A. (2020) · British journal of surgery · doi:10.1002/bjs.11433 · Cited by 92
Sudden cardiac death and obesity
Plourde, B., SARRAZIN, J., Nault, I., & Poirier, P. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.952283 · Cited by 93
Won, H., Natarajan, P., Dobbyn, A. L., Jordan, D. M., Roussos, P., Lage, K., Raychaudhuri, S., Stahl, E. A., & Do, R. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005622 · Cited by 94
Mok, M. T. C., Allende, R., Leipsic, J. A., Altisent, O. A., Trigo, M. D., Campelo‐Parada, F., DeLarochellière, R., Dumont, É., Doyle, D. J., Côté, M., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.015 · Cited by 92
Obesity: pathophysiology and therapeutic interventions
Kong, Y., Yang, H., Nie, R., Zhang, X., Zuo, F., Zhang, H., & Nian, X. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00264-9 · Cited by 89
Cardiovascular Risk-Benefit Profile of Sibutramine
Scheen, A. J. (2010) · American Journal of Cardiovascular Drugs · doi:10.2165/11584800-000000000-00000 · Cited by 89
de Jonge, P., Rosmalen, J. G. M., Kema, I. P., Doornbos, B., van Melle, J. P., Pouwer, F., & Kupper, N. H. M. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.025 · Cited by 90
Oh, T. J., Moon, J. H., Choi, S. H., Lim, S. K., Park, K. S., Cho, N. H., & Jang, H. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01239 · Cited by 94
Molecular insights of exercise therapy in disease prevention and treatment
Walzik, D., Chirino, T. Y. W., Zimmer, P., & Joisten, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01841-0 · Cited by 95
Nutritional Risk Index predicts mortality in hospitalized advanced heart failure patients
Adejumo, O. L., Koelling, T. M., & Hummel, S. L. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.05.027 · Cited by 89
Balla, S. R., Cyr, D. D., Lokhnygina, Y. V., Becker, R. C., Berkowitz, S. D., BREITHARDT, G. E., Fox, K. A. A., Hacke, W., Halperin, J. L., Hankey, G. J., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.03.028 · Cited by 88
Impact of Discrepancies in General and Abdominal Obesity on Major Adverse Cardiac Events
Choi, D., Choi, S., Son, J. S., Oh, S. W., & Park, S. M. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013471 · Cited by 91
Ptacek, S. G., Irving, G. F., Čermáková, P., Eriksdotter, M., & Religa, D. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.199 · Cited by 91
Management of Obesity in Cardiovascular Practice
Després, J.-P., Carpentier, A. C., Tchernof, A., Neeland, I. J., & Poirier, P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.035 · Cited by 87
Measures of adiposity predict interleukin-6 responses to repeated psychosocial stress
McInnis, C. M., Thoma, M. V., Gianferante, D., Hanlin, L. C., Chen, X., Breines, J. G., Hong, S., & Rohleder, N. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.07.018 · Cited by 88
The economic burden of obesity in Italy: a cost-of-illness study
d’Errico, M., Pavlova, M., & Spandonaro, F. (2021) · The European Journal of Health Economics · doi:10.1007/s10198-021-01358-1 · Cited by 87
Donnellan, E., Wazni, O. M., Kanj, M. H., Baranowski, B. J., Cremer, P. C., Harb, S. C., McCarthy, C. P., McEvoy, J. W., Elshazly, M. B., Aagaard, P., et al. (2019) · EP Europace · doi:10.1093/europace/euz183 · Cited by 91
The complex spectrum of forensic issues arising from obesity
Byard, R. W. (2012) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-012-9322-5 · Cited by 86
Vezza, T., Rodríguez‐Nogales, A., Algieri, F., Garrido‐Mesa, J., Romero, M., Sánchez, M., Toral, M., Martín-García, B., Gómez‐Caravaca, A. M., Arraéz-Román, D., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104487 · Cited by 89
Wan, Y., Xia, J., Xu, J., Chen, L., Yang, Y., Wu, J., Tang, F., Ao, H., & Peng, C. Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106002 · Cited by 87
Schenkeveld, L., Magro, M., Oemrawsingh, R. M., Lenzen, M. J., de Jaegere, P. P. T., van Geuns, R., Serruys, P. W. J. C., & van Domburg, R. T. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000535 · Cited by 86
Paradoxical Preservation of Vascular Function in Severe Obesity
Biasucci, L. M., Graziani, F., Rizzello, V., Liuzzo, G., Guidone, C., Caterina, A. R. D., Brugaletta, S., Mingrone, G., & Crea, F. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.02.016 · Cited by 89
Neural Mechanisms in Cardiovascular Health and Disease
Ziegler, K. A., Engelhardt, S. H., Carnevale, D., McAlpine, C. S., Guzik, T. J., Dimmeler, S., & Świrski, F. K. (2025) · Circulation Research · doi:10.1161/circresaha.125.325580 · Cited by 89
Atherosclerosis in Systemic Lupus Erythematosus
Stojan, G., & Petri, M. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31829dd857 · Cited by 86
ADIPOQ Polymorphisms, Monounsaturated Fatty Acids, and Obesity Risk: The GOLDN Study
Warodomwichit, D., Shen, J., Arnett, D. K., Tsai, M. Y., Kabagambe, E. K., Peacock, J. M., Hixson, J. E., Straka, R. J., Province, M. A., An, P., et al. (2009) · Obesity · doi:10.1038/oby.2008.583 · Cited by 85
Schutter, A. D., Lavie, C. J., Kachur, S. M., Patel, D. A., & Milani, R. V. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.04.025 · Cited by 85
Self-citationToita, R., Kawano, T., Murata, M., & Kang, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.018 · Cited by 89
Role of Policy and Government in the Obesity Epidemic
Novak, N. L., & Brownell, K. D. (2012) · Circulation · doi:10.1161/circulationaha.111.037929 · Cited by 91
Heart failure with preserved ejection fraction: present status and future directions
Yoon, S., & Eom, G. H. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0323-2 · Cited by 87
Wang, T., Zhao, Z., Yu, X., Zeng, T., Xu, M., Xu, Y., Hu, R., Chen, G., Su, Q., Mu, Y., et al. (2021) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100277 · Cited by 85
Fasting Induces an Anti‐Inflammatory Effect on the Neuroimmune System Which a High‐Fat Diet Prevents
Lavin, D. N., Joesting, J. J., Chiu, G. S., Moon, M. L., Meng, J., Dilger, R. N., & Freund, G. G. (2011) · Obesity · doi:10.1038/oby.2011.73 · Cited by 84
Manna, P., & Jain, S. K. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373949 · Cited by 87
Metabolism and the heart: An overview of muscle, fat, and bone metabolism in heart failure
Loncar, G., Fülster, S., von Haehling, S., & POPOVIC, V. M. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.09.079 · Cited by 85
Alterations of specific lipid groups in serum of obese humans: a review
Mika, A., & Śledziński, T. (2016) · Obesity Reviews · doi:10.1111/obr.12475 · Cited by 83
Body Mass Index, Initial Neurological Severity and Long-Term Mortality in Ischemic Stroke
Ryu, W., Lee, S., Kim, C. K., Kim, B. J., & Yoon, B. (2011) · Cerebrovascular Diseases · doi:10.1159/000328250 · Cited by 83
Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease
Rychli, K., Huber, K., & Wojta, J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903241641 · Cited by 83
Lai, H.-L., & Li, Y.-M. (2011) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2011.05670.x · Cited by 82
Moholdt, T. T., Lavie, C. J., & Nauman, J. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.01.043 · Cited by 82
Self-citationReview on the Current State of Diacylglycerol Production Using Enzymatic Approach
Phuah, E., Tang, T., Lee, Y., Choong, T. S.-Y., Tan, C. P., & Lai, O. M. (2015) · Food and Bioprocess Technology · doi:10.1007/s11947-015-1505-0 · Cited by 82
Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs
Koh, K. K., Quon, M. J., Han, S. H., Lee, Y., Kim, S., Koh, Y., & Shin, E. K. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.11.017 · Cited by 82
Rapamycin Blocks Induction of the Thermogenic Program in White Adipose Tissue
Tran, C. M., Mukherjee, S., Ye, L., Frederick, D. W., Kissig, M., Davis, J. G., Lamming, D. W., Seale, P., & Baur, J. A. (2016) · Diabetes · doi:10.2337/db15-0502 · Cited by 84
Ma, Q., Zhou, X., Sun, Y., Hu, L., Zhu, J., Shao, C., Meng, Q., & Shan, A. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01023 · Cited by 81
You, J. S., Lee, Y. J., Kim, K. S., Kim, S. H., & Chang, K. J. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.01.003 · Cited by 83
Ali, S. F., Smith, E. E., Bhatt, D. L., Fonarow, G. C., & Schwamm, L. H. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000171 · Cited by 81
Obesity Paradox in Heart Failure: A Heavy Matter
Nagarajan, V., Kohan, L., Holland, E., Keeley, E. C., & Mazimba, S. (2016) · ESC Heart Failure · doi:10.1002/ehf2.12120 · Cited by 82
A Systematic Review of Behavioural Interventions Promoting Healthy Eating among Older People
Zhou, X., Pérez-Cueto, F. J. A., dos Santos, Q., Monteleone, E., Giboreau, A., Appleton, K. M., Bjørner, T., Bredie, W. L. P., & Hartwell, H. (2018) · Nutrients · doi:10.3390/nu10020128 · Cited by 85
Boido, A., Ceriani, V., Cetta, F., Lombardi, F., & Pontiroli, A. E. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.01.011 · Cited by 80
Skeletal muscle mass and risk of death in an elderly population
Chuang, S., Chang, H.-Y., Lee, M.-S., Chen, R. C.-Y., & Pan, W. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.11.010 · Cited by 81
Consequences of obesity and weight loss: a devil's advocate position
Brown, R. E., & Kuk, J. L. (2014) · Obesity Reviews · doi:10.1111/obr.12232 · Cited by 83
Neeland, I. J., Das, S. R., Simon, D. N., Diercks, D. B., Alexander, K. P., Wang, T. Y., & de Lemos, J. A. (2017) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcx010 · Cited by 79
Excessive sedentary time during in-patient stroke rehabilitation
Barrett, M., Snow, J. C., Kirkland, M. C., Kelly, L. P., Gehue, M., Downer, M. B., McCarthy, J., & Ploughman, M. (2018) · Topics in Stroke Rehabilitation · doi:10.1080/10749357.2018.1458461 · Cited by 79
Khera, R., Pandey, A., Ayers, C. R., Carnethon, M. R., Greenland, P., Ndumele, C. E., Nambi, V., Seliger, S. L., Chaves, P. H. M., Safford, M. M., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.23242 · Cited by 79
Volpe, M., & Gallo, G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1136340 · Cited by 87
YKL-40 is Elevated in Morbidly Obese Patients and Declines After Weight Loss
Hempen, M., Kopp, H.-P., Elhenicky, M., Höbaus, C., Brix, J., Koppensteiner, R., Schernthaner, G., & Schernthaner, G.-H. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9917-4 · Cited by 79
Åsvold, B. O., Bjøro, T., & VATTEN, L. J. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0087 · Cited by 79
Doshi, M., Streja, E., Rhee, C. M., Park, J., Ravel, V., Soohoo, M., Moradi, H., Lau, W. L., Mehrotra, R., Kuttykrishnan, S., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv379 · Cited by 79
Saito, H., Matsue, Y., Kamiya, K., Kagiyama, N., Maeda, D., Endo, Y., Ueno, H., Yoshioka, K., Mizukami, A., Saito, K., et al. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03168-3 · Cited by 78
Polak, J., Kotrč, M., Wedellová, Z., Jabor, A., Málek, I., Kautzner, J., Kazdová, L., & Melenovský, V. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.042 · Cited by 80
Mediterranean diet and coronary heart disease: Is obesity a link? – A systematic review
Kastorini, C. M., Milionis, H. J., Goudevenos, J. A., & Panagiotakos, D. B. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.04.006 · Cited by 80
The Obesity Paradox and Weight Loss
MYERS, J. N., Lata, K., Chowdhury, S., McAuley, P. A., Jain, N., & Froelicher, V. F. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.04.018 · Cited by 77
Yeboah, P., Hsu, F., Bertoni, A. G., & Yeboah, J. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.11.016 · Cited by 79
Helicobacter pylori Infection Impairs Endothelial Function Through an Exosome‐Mediated Mechanism
Xia, X., Zhang, L., Chi, J., Li, H., Liu, X., Hu, T., Li, R., Guo, Y., Zhang, X., Wang, H., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014120 · Cited by 77
Metadata
- Authors
- Lavie, C. J., Milani, R. V., & Ventura, H. O.
- Affiliations
- Ochsner Health System (US)
- Ochsner Medical Center (US)
- Corresponding author
- Lavie, Carl J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 53
- Issue
- 21
- Pages
- 1925-1932
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1598667444
- Cited by
- 2,326
- References
- 96
- Citations by year
- 2026: 87 · 2025: 110 · 2024: 129 · 2023: 107 · 2022: 130 · 2021: 159 · 2020: 162 · 2019: 135 · 2018: 143 · 2017: 141 · 2016: 157 · 2015: 139 · 2014: 152 · 2013: 153 · 2012: 135
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, cardiovascular disease, obesity paradox, heart failure, coronary artery disease, sudden cardiac death, atrial fibrillation, hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular risk factors, weight loss, obesity pathogenesis
- MeSH terms
- Cardiovascular Diseases, Humans, Obesity, Risk Factors, United States, Weight Loss, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
